Skip to main content
SpringerLink
Log in

Unbeliebte Leitlinienempfehlung: Spironolacton bei Herzinsuffizienz im Alter

  • Literatur kompakt
  • Published:
CardioVasc Aims and scope

Aldosteronantagonisten werden für die Therapie der Herzinsuffizienz empfohlen, aber bei älteren Patienten wegen unsicherer Studienlage, möglicher Nebenwirkungen und der Vorschrift engmaschiger Kontrollen häufig nicht verordnet.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Bayoumi E et al. Spironolactone and Outcomes in Older Patients with Heart Failure and Reduced Ejection Fraction. Am J Med. 2019; 32:71–80

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. München, Deutschland

    Heinrich Holzgreve (Internist)

Authors
  1. Heinrich Holzgreve
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Holzgreve, H. Unbeliebte Leitlinienempfehlung: Spironolacton bei Herzinsuffizienz im Alter. CV 19, 48–49 (2019). https://doi.org/10.1007/s15027-019-1517-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15027-019-1517-1

Search

Navigation